Skip to main content
Erschienen in: Annals of Behavioral Medicine 5/2015

01.10.2015 | Brief Report

Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates

verfasst von: Amy J. Starosta, MA, George Luta, PhD, Catherine A. Tomko, BA, Marc D. Schwartz, PhD, Kathryn L. Taylor, PhD

Erschienen in: Annals of Behavioral Medicine | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The impact of decision aids on prostate cancer screening outcomes has been inconsistent.

Purpose

We assessed whether pre-existing attitudes moderated the impact of decision aids on screening.

Methods

Men aged 45–70 (56.2 % Caucasian, 39.9 % African-American) were randomly assigned to a print decision aid (N = 630), a web decision aid (N = 631), or usual care (N = 632). Telephone interviews assessed pro/con screening attitudes and screening behaviors at baseline, 1-month and 13-months post-randomization.

Results

Logistic regression analyses revealed significant arm by attitude interactions: Higher baseline cons scores predicted lower screening in the print (OR = 0.60 (95 % CI: 0.40, 0.92)) and web (OR = 0.61 (95 % CI: 0.40, 0.91)) arms but not in usual care (OR = 1.34 (95 % CI: 0.90, 2.00)).

Conclusions

The decision aids amplified the impact of men’s baseline attitudes about limitations of screening: Compared to the usual care arm, men in both decision aid arms were less likely to be screened when they perceived more limitations of screening.
Literatur
2.
Zurück zum Zitat Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014; 64: 30-51.CrossRefPubMed Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014; 64: 30-51.CrossRefPubMed
3.
Zurück zum Zitat Justman S. Uninformed consent: mass screening for prostate cancer. Bioethics. 2012; 26: 143-148.CrossRefPubMed Justman S. Uninformed consent: mass screening for prostate cancer. Bioethics. 2012; 26: 143-148.CrossRefPubMed
4.
Zurück zum Zitat Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 120-134.CrossRefPubMed Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 120-134.CrossRefPubMed
6.
Zurück zum Zitat Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst. 2009; 101: 1216-1220.PubMedCentralCrossRefPubMed Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst. 2009; 101: 1216-1220.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Sheridan SL, Golin C, Bunton A, et al. Shared decision making for prostate cancer screening: The results of a combined analysis of two practice-based randomized controlled trials. BMC Med Inform Decis Mak. 2012; 12: 130.PubMedCentralCrossRefPubMed Sheridan SL, Golin C, Bunton A, et al. Shared decision making for prostate cancer screening: The results of a combined analysis of two practice-based randomized controlled trials. BMC Med Inform Decis Mak. 2012; 12: 130.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Lepore SJ, Wolf RL, Basch CE, et al. Informed decision making about prostate cancer testing in predominantly immigrant black men: A randomized controlled trial. Ann Behav Med. 2012; 44: 320-330.PubMedCentralCrossRefPubMed Lepore SJ, Wolf RL, Basch CE, et al. Informed decision making about prostate cancer testing in predominantly immigrant black men: A randomized controlled trial. Ann Behav Med. 2012; 44: 320-330.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Williams RM, Davis KM, Luta G, et al. Fostering informed decisions: A randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer. Patient Educ Couns. 2013; 91: 329-336.PubMedCentralCrossRefPubMed Williams RM, Davis KM, Luta G, et al. Fostering informed decisions: A randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer. Patient Educ Couns. 2013; 91: 329-336.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Stamatiou K, Skolarikos A, Heretis I, et al. Does educational printed material manage to change compliance with prostate cancer screening? World J Urol. 2008; 26: 365-373.CrossRefPubMed Stamatiou K, Skolarikos A, Heretis I, et al. Does educational printed material manage to change compliance with prostate cancer screening? World J Urol. 2008; 26: 365-373.CrossRefPubMed
11.
Zurück zum Zitat Taylor KL, Williams RM, Davis K, et al. Decision making in prostate cancer screening using decision aids vs usual care: A randomized clinical trial. JAMA Intern Med. 2013; 173: 1704-1712.PubMedCentralPubMed Taylor KL, Williams RM, Davis K, et al. Decision making in prostate cancer screening using decision aids vs usual care: A randomized clinical trial. JAMA Intern Med. 2013; 173: 1704-1712.PubMedCentralPubMed
12.
Zurück zum Zitat Dorfman CS, Williams RM, Kassan EC, et al. The development of a web- and a print-based decision aid for prostate cancer screening. BMC Med Inform Decis Mak. 2010; 10: 12.PubMedCentralCrossRefPubMed Dorfman CS, Williams RM, Kassan EC, et al. The development of a web- and a print-based decision aid for prostate cancer screening. BMC Med Inform Decis Mak. 2010; 10: 12.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Tomko C, Davis KM, Luta G, Krist AH, Woolf SH, Taylor KL. A comparison of web-based versus print-based decision aids for prostate cancer screening: Participants' evaluation and utilization. J Gen Intern Med. 2014; Sep 3. [Epub ahead of print]. DOI:10.1007/s11606-014-2994-7. Tomko C, Davis KM, Luta G, Krist AH, Woolf SH, Taylor KL. A comparison of web-based versus print-based decision aids for prostate cancer screening: Participants' evaluation and utilization. J Gen Intern Med. 2014; Sep 3. [Epub ahead of print]. DOI:10.​1007/​s11606-014-2994-7.
14.
Zurück zum Zitat Consedine NS, Morgenstern AH, Kudadjie-Gyamfi E, Magai C, Neugut AI. Prostate cancer screening behavior in men from seven ethnic groups: The fear factor. Cancer Epidemiol Biomarkers Prev. 2006; 15: 228-237.CrossRefPubMed Consedine NS, Morgenstern AH, Kudadjie-Gyamfi E, Magai C, Neugut AI. Prostate cancer screening behavior in men from seven ethnic groups: The fear factor. Cancer Epidemiol Biomarkers Prev. 2006; 15: 228-237.CrossRefPubMed
15.
Zurück zum Zitat Gorin MA, Soloway CT, Eldefrawy A, Soloway MS. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology. 2011; 77: 588-591.CrossRefPubMed Gorin MA, Soloway CT, Eldefrawy A, Soloway MS. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology. 2011; 77: 588-591.CrossRefPubMed
16.
Zurück zum Zitat McDowell ME, Occhipinti S, Chambers SK. Classifying the reasons men consider to be important in prostate-specific antigen (PSA) testing decisions: Evaluating risks, lay beliefs, and informed decisions. Ann Behav Med. 2013; 46: 322-335.CrossRefPubMed McDowell ME, Occhipinti S, Chambers SK. Classifying the reasons men consider to be important in prostate-specific antigen (PSA) testing decisions: Evaluating risks, lay beliefs, and informed decisions. Ann Behav Med. 2013; 46: 322-335.CrossRefPubMed
17.
Zurück zum Zitat Silberbogen AK, Busby AK, Ulloa EW. Impact of psychological distress on prostate cancer screening in U.S. military veterans. Am J Mens Health. 2013; 8: 399-408.CrossRefPubMed Silberbogen AK, Busby AK, Ulloa EW. Impact of psychological distress on prostate cancer screening in U.S. military veterans. Am J Mens Health. 2013; 8: 399-408.CrossRefPubMed
18.
Zurück zum Zitat Ross L, Kohler CL, Grimley DM, Green BL, Anderson-Lewis C. Toward a model of prostate cancer information seeking: Identifying salient behavioral and normative beliefs among African American men. Health Educ Behav. 2007; 34: 422-440.CrossRefPubMed Ross L, Kohler CL, Grimley DM, Green BL, Anderson-Lewis C. Toward a model of prostate cancer information seeking: Identifying salient behavioral and normative beliefs among African American men. Health Educ Behav. 2007; 34: 422-440.CrossRefPubMed
19.
Zurück zum Zitat Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL. Men's perspectives on selecting their prostate cancer treatment. J Natl Med Assoc. 2011; 103: 468-478.PubMedCentralPubMed Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL. Men's perspectives on selecting their prostate cancer treatment. J Natl Med Assoc. 2011; 103: 468-478.PubMedCentralPubMed
20.
Zurück zum Zitat O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009; CD001431. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009; CD001431.
21.
Zurück zum Zitat Rakowski W, Andersen MR, Stoddard AM, et al. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol. 1997; 16: 433-441.CrossRefPubMed Rakowski W, Andersen MR, Stoddard AM, et al. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol. 1997; 16: 433-441.CrossRefPubMed
22.
Zurück zum Zitat Chan JM, Jou RM, Carroll PR. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004; 172: S13-S16.CrossRefPubMed Chan JM, Jou RM, Carroll PR. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004; 172: S13-S16.CrossRefPubMed
23.
Zurück zum Zitat Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008; 17: 748-757.CrossRefPubMed Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008; 17: 748-757.CrossRefPubMed
Metadaten
Titel
Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates
verfasst von
Amy J. Starosta, MA
George Luta, PhD
Catherine A. Tomko, BA
Marc D. Schwartz, PhD
Kathryn L. Taylor, PhD
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Annals of Behavioral Medicine / Ausgabe 5/2015
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-015-9692-5

Weitere Artikel der Ausgabe 5/2015

Annals of Behavioral Medicine 5/2015 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.